spillovers. -- economies of scale and scope ; spillovers ; competition ; R&D ; innovation process …&D competition and technological spillovers as explanatory variables and test whether the effect of these variables on the success of … discovery stage of innovation, while in the later development stage, the effects of competition outweigh any benefits from …

&D competition and technological spillovers as explanatory variables and test whether the effect of these variables on the success of … discovery stage of innovation, while in the later development stage, the effects of competition outweigh any benefits from … factors of success in drug development programs at different stages of innovation process. We use economies of scale, scope, R …

proximity of an R&D project towards other projects within a firm's portfolio as well as R&D competition factors. Additionally …&D diversification is governed by the economies of scope as well as the escape competition motive. Moreover, it is found that competition … rather than spillovers in the niche where an R&D project is developed defines firms' decisions to diversify. …

proximity of an R&D project towards other projects within a firm's portfolio as well as R&D competition factors. Additionally …&D diversification is governed by the economies of scope as well as the escape competition motive. Moreover, it is found that competition … rather than spillovers in the niche where an R&D project is developed defines firms' decisions to diversify …

shares. We investigate how pharmaceutical firms use mergers and acquisitions to boost their innovation performance which has … successful in their innovation endeavours than firms with other goal orientation. Further, the firms’ prior acquisition … experience appears to aid their innovation performance. However, we found that target size can affect the post …

proximity of an R&D project towards other projects within a firm's portfolio as well as R&D competition factors. Additionally …&D diversification is governed by the economies of scope as well as the escape competition motive. Moreover, it is found that competition … rather than spillovers in the niche where an R&D project is developed defines firms' decisions to diversify. …

shares. We investigate how pharmaceutical firms use mergers and acquisitions to boost their innovation performance which has … successful in their innovation endeavours than firms with other goal orientation. Further, the firms' prior acquisition … experience appears to aid their innovation performance. However, we found that target size can affect the post …

What is the interaction between competition, R&D investments, and the financing choices of R&D-intensive firms …? Motivated by existing theories, we hypothesize that as competition increases, R&D-intensive firms will: (1) increase R … industries, as well as heterogeneity within the biopharma industry, in response to an exogenous change in competition. We also …